https://invesbrain.com/jay-bradners-nibr-exit-sets-off-a-succession-plan-at-merck-dyne-and-morphosys-fill-major-rd-roles/
Jay Bradner’s NIBR exit sets off a succession plan at Merck; Dyne and MorphoSys fill major R&D roles